Saras Kuntari
Unknown Affiliation

Published : 5 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 5 Documents
Search

Faktor-Faktor yang Memengaruhi Ketahanan Hidup Pasien HIV/AIDS: A review joko tri atmojo; Vivi Erlina Maylanda; Aprilia Tina Prastiwi; Aquartuti Tri Darmayanti; Saras Kuntari
Jurnal Informasi Kesehatan Indonesia (JIKI) Vol 5 No 2 (2019): Jurnal Informasi Kesehatan Indonesia (JIKI)
Publisher : Politeknik Kesehatan Kemenkes Malang (State Health Polytechnic of Malang)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31290/jiki.v5i2.1492

Abstract

Until now there is no vaccine that can fight HIV / AIDS. Antiretroviral Agents (ARVs) can only provide survival by slowing the reproduction of viruses. The purpose of this review is to describe the factors that can affect survival (PLWHA) after ARV administration. factors that can affect the survival / survival of people with HIV / AIDS (PLWHA) in addition to the provision of antiretroviral drugs. This review was conducted by the author in January - March 2019, by searching databases including PubMed, Google scholar, and open access science direct. In this review, it has been explained various factors that affect the survival of PLWHA who receive ARV treatment, including: Birth sex, age, nutritional status, CD4 levels and co-infection.
EFEK PERAWATAN PALIATIF DI UNIT GAWAT DARURAT DAN RASIONALITAS UNTUK DIKEMBANGKAN DI MASA PANDEMI COVID-19 Joko Tri Atmojo; Lilik Hanifah; Rina Tri Handayani; Rejo Rejo; Catur Setyorini; Nova Rahma Widyaningrum; Siti Maesaroh; Isnani Nurhayati; Anita Dewi Lieskusumastuti; Andriani Noerlita Ningrum; Tri Yuniarti; Sri Sayekti Heni Sunaryanti; Sri Iswahyuni; Sabatun Sabatun; Kiki Puspitasary; Nurrochim Nurrochim; Daryanto Daryanto; Ani Nur Fauziah; Meliana Novitasari; Etik Sulistyorini; Yesi Ihdina Fityatal Hasanah; Indarto Indarto; Karmadi Karmadi; Sri Suparti; Ahmad Rois Syujak; Anisa Hidayati; Rinandita Febri Susanti; Rohmi Rohmi; Ndaru Syukma Putra; Galuh Sindi Wardhani; Mifta Aditya; Heni Ernawati; Dewi Arradini; Anggie Pradana Putri; Selvia Anggitasari; Eva Leny Alviani; Saras Kuntari; Aquartuti Tri Darmayanti; Aris Widiyanto; Ahmad Syauqi Mubarok
Avicenna : Journal of Health Research Vol 4, No 2 (2021): OKTOBER
Publisher : STIKES Mamba'ul 'Ulum Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36419/avicenna.v4i2.536

Abstract

EFEKTIVITAS MASKER MEDIS DALAM MENCEGAH PENULARAN COVID-19 Joko Tri Atmojo; Lilik Hanifah; Rina Tri Handayani; Rejo Rejo; Catur Setyorini; Nova Rahma Widyaningrum; Siti Maesaroh; Isnani Nurhayati; Anita Dewi Lieskusumastuti; Andriani Noerlita Ningrum; Tri Yuniarti; Sri Sayekti Heni Sunaryanti; Sri Iswahyuni; Sabatun Sabatun; Kiki Puspitasary; Nurrochim Nurrochim; Daryanto Daryanto; Ani Nur Fauziah; Meliana Novitasari; Etik Sulistyorini; Yesi Ihdina Fityatal Hasanah; Indarto Indarto; Karmadi Karmadi; Sri Suparti; Ahmad Rois Syujak; Anisa Hidayati; Rinandita Febri Susanti; Rohmi Rohmi; Ndaru Syukma Putra; Galuh Sindi Wardhani; Mifta Aditya; Heni Heni Ernawati; Dewi Arradini; Anggie Pradana Putri; Budi Setiawan Manurung; Tio Guntur Prabowo; Saras Kuntari; Aquartuti Tri Darmayanti; Aris Widiyanto; Ahmad Syauqi Mubarok
Avicenna : Journal of Health Research Vol 4, No 2 (2021): OKTOBER
Publisher : STIKES Mamba'ul 'Ulum Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36419/avicenna.v4i2.537

Abstract

FAKTOR-FAKTOR YANG MEMENGARUHI KETAHANAN HIDUP PASIEN HIV/AIDS: A REVIEW joko tri atmojo; Vivi Erlina Maylanda; Aprilia Tina Prastiwi; Aquartuti Tri Darmayanti; Saras Kuntari
Jurnal Informasi Kesehatan Indonesia (JIKI) Vol 5 No 2 (2019): Jurnal Informasi Kesehatan Indonesia (JIKI)
Publisher : Politeknik Kesehatan Kemenkes Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31290/jiki.v5i2.1492

Abstract

Sampai saat ini belum ada vaksin yang dapat melawan HIV/AIDS. Antiretroviral Agents (ARV) hanya dapat memberkan ketahanan hidup dengan memperlambat reproduksi virus. Tujuan review ini adalah menjabarkan faktor-faktor yang dapat mempengaruhi ketahanan hidup / survival (ODHA) setelah pemberian ARV. faktor yang dapat mempengaruhi ketahanan hidup / survival dari orang dengan HIV / AIDS (ODHA) selain pemberian ARV. Review ini dilakukan penulis pada Januari – Maret 2019, dengan menelusuri database diantaranya PubMed, Google scholar, dan open access science direct. Pada review ini telah dijelaskan berbagai faktor yang mempengaruhi ketahanan hidup ODHA yang menerima pengobatan ARV, diantaranya : jenis kelamin, usia, status gizi, kadar CD4 dan juga koinfeksi. Sampai saat ini belum ada vaksin yang dapat melawan HIV/AIDS. Antiretroviral Agents (ARV) hanya dapat memberkan ketahanan hidup dengan memperlambat reproduksi virus. Tujuan review ini adalah menjabarkan faktor-faktor yang dapat mempengaruhi ketahanan hidup / survival (ODHA) setelah pemberian ARV. faktor yang dapat mempengaruhi ketahanan hidup / survival dari orang dengan HIV / AIDS (ODHA) selain pemberian ARV. Review ini dilakukan penulis pada Januari – Maret 2019, dengan menelusuri database diantaranya PubMed, Google scholar, dan open access science direct. Pada review ini telah dijelaskan berbagai faktor yang mempengaruhi ketahanan hidup ODHA yang menerima pengobatan ARV, diantaranya : jenis kelamin, usia, status gizi, kadar CD4 dan juga koinfeksi.
Definisi dan Jalur Penularan Severe Acute Respiratory Syndrome Coronavirus 2 atau COVID 19 joko tri atmojo; Prima Soultoni Akbar; Saras Kuntari; Ika Yulianti; Aquanturi Tri Darmayanti
Jurnal Pendidikan Kesehatan Vol 9 No 1 (2020): Jurnal Pendidikan kesehatan
Publisher : Poltekkes Kemenkes Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31290/jpk.v9i1.1513

Abstract

Since it was first reported at the end of 2019 Severe Acute Respiratory Syndrome Coronavirus 2 or SARS CoV 2 or COVID 19 has infected more than 2 million people in just under 5 months worldwide. Based on the above data the author will make a review and explain the definitions and also various routes of transmission of infection based on evidence that has been published and summarized. The review was carried out in April 2020, by searching the article through an online database and keywords Review AND COVID 19 OR Severe Acute Respiratory Syndrome Coronavirus 2 AND Review OR Coronavirus Disease 2019 AND Review AND transmission route. SARS CoV 2 or COVID 19 is a virus of the type of beta coronavirus with a higher transmission rate than SAR CoV or MERS. The most active human to human transmission pathway is through close contact with droplets and aerosols, although the virus is still present in feces, tears and urine. But the potential for transmission still needs to be studied. The incubation period of the virus is 0 until 24 days with an average of the first symptoms until death is 3 until 14 days.